recent transactionshistorical transactions

Aerogen, Inc.
Offer was a 159% premium to common
shareholders

Definitive agreement: August 2005
Closed: October 2005

Case Study      Press Release


Location:
Mountain View, CA
CEO: John Hodgman
CFO: Bubba Breuil
Board of Directors: Jean-Jacques Bienaimé, Bernard Collins, Dick Daly, Phyllis Gardner, Ehud Ivri, Robert Roe, Jane Shaw, John Hodgman

- Aerogen develops products based on its OnQ Aerosol Generator technology to improve the treatment of respiratory disorders in the acute care setting.

- Aquilo worked with management, board and shareholders to deliver maximum value to all parties.

- The offer represented a 159% premium to common shareholders.